フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Fusion Antibodies PLC on Wednesday announced the approval of a grant funding application to The Northern Ireland Prec ...
Fusion Antibodies PLC 04 December 2024 The information contained within this announcement is deemed by the Company to constitute inside...
Fusion Antibodies PLC on Tuesday said its loss narrowed in the first half of its current financial year, as revenue m ...
Fusion Antibodies PLC 19 November 2024 The information contained within this announcement is deemed by the Company to constitute inside...
Fusion Antibodies PLC 16 October 2024 16 October 2024 Fusion Antibodies plc ("Fusion" or the "Company") Director/PDMR Shareholding ...
Fusion Antibodies PLC 16 October 2024 The information contained within this announcement is deemed by the Company to constitute inside...
PLC - Belfast-based contract researcher that provides discovery, design and optimisation services for therapeutic ant ...
Fusion Antibodies PLC 08 October 2024 Fusion Antibodies plc ("Fusion" or the "Company") Result of AGM Fusion Antibodies plc (AIM: FAB...
Fusion Antibodies PLC 08 October 2024 The information contained within this announcement is deemed by the Company to constitute inside...
Fusion Antibodies PLC 02 October 2024 2 October 2024 Fusion Antibodies plc ("Fusion" or the "Company") Block admission six monthly return...
Fusion Antibodies PLC 12 September 2024 12 September 2024 Fusion Antibodies plc ("Fusion" or the "Company") Posting of Annual Report...
Fusion Antibodies PLC 09 September 2024 9 September 2024 Fusion Antibodies plc ("Fusion" or the "Company") Director/PDMR Shareholding ...
Fusion Antibodies PLC 05 September 2024 5 September 2024 Fusion Antibodies plc ("Fusion" or the "Company") Director/PDMR Shareholding ...
Fusion Antibodies PLC 05 September 2024 The information contained within this announcement is deemed by the Company to constitute inside...
Fusion Antibodies PLC on Wednesday said it is expanding its collaboration agreement with the National Cancer Institut ...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約